Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: General Surgical Innovations/USSC

This article was originally published in The Gray Sheet

Executive Summary

General Surgical Innovations/USSC: Firms terminate early a distribution agreement that had given U.S. Surgical exclusive rights in the U.S. and certain international markets to sell GSI's Spacemaker I and II balloon dissection systems, GSI announces Nov. 15. The deal was set to expire in March 1997. Early termination of the deal allows GSI to seek expansion of a July agreement with Johnson & Johnson's Ethicon subsidiary for distribution of GSI products in the hernia and incontinence markets. GSI says it expects revenues for its hernia procedures to fluctuate for the next few quarters as a result of the partnership change...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007100

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel